In premature infants born before 35 weeks of gestation, ZDV shoul

In premature infants born before 35 weeks of gestation, ZDV should be administered at the above doses, but only 2 times a day until 2 weeks after birth and 3 times a day thereafter [7] and [15]. In Palbociclib nmr addition, mitochondrial disorders of the newborn and future fatal lactic acidosis, as well as HELLP syndrome in pregnant women [16] should be taken into account. Other preventive measures are maintaining mothers’ blood HIV RNA level below the detection limit and maintaining immune function for as

long as possible. For this purpose, ART and preventive treatments for opportunistic malignancies and infections are performed [17]. ART is usually performed as a combination therapy of more than 3 drugs (HAART) [17]. The selection of anti-HIV drugs and the timing of the initiation of treatment are particularly important. ART for children is limited to only 3 types of drugs: nucleoside

reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), click here and protease inhibitors (PIs). The use of other new drugs for children is limited because of their restrictions for use and the dosage forms required. A combination of 1 PI and 2 NNRTIs can be administered to children. The NNRTI of first choice is efavirenz (EFV), because of its high efficacy and its availability as capsules. Nevirapine (NVP) syrup can also be used in children; however, it has side effects of severe rash and liver dysfunction. Thiamet G After puberty, the treatment for HIV is the same as in adults. Points that require special attention in HIV treatment are multidrug interactions and side effects of individual drugs. HIV RNA levels and CD4+ cell counts must be measured regularly to estimate the efficacy of the drug and to detect drug resistance. In addition, side effects of and adherence to the treatment should be monitored. PIs and NNRTIs are metabolized by liver cytochrome P450 (CYP). Attention must be paid to their interaction with other drugs and herbs that

are also metabolized by CYP [18]. Immune reconstitution syndrome (opportunistic malignancies and opportunistic infections causing recurrence and re-exacerbation) might occur when ART is initiated after the onset of immunodeficiency [19]. It is caused by an induction of the suppressed immune response or inflammatory response. Anti-HIV drugs that are administered during pregnancy or to neonates have been associated with mitochondrial toxicity in neonates. Two deaths in Europe due to mitochondrial dysfunction in HIV-uninfected infants that were born to infected mothers who were treated with anti-HIV drugs during pregnancy were reported [20] and [21]. Therefore, we should be concerned about the subsequent onset of neuromuscular diseases among children who receive antiretroviral drugs, particularly during the neonatal period.

Correspondingly, ultrasound shows a flattening of the nerve under

Correspondingly, ultrasound shows a flattening of the nerve under the arcade with a proximal swelling

in the sulcus. Cross-sectional areas greater than 0.1 cm2 accompanied by a hypoechoic appearance and loss of the honeycomb echotexture, are diagnostic for cubital tunnel syndrome. Another entity is caused by a repetitive subluxation or luxation of the nerve out of the sulcus leading to chronic pressure damage. Smad family A lacking or loose humeroulnar arcade is postulated as a reason for this. In the case of subluxation, the ulnar nerve is located at the tip of the medial epicondyle at maximum elbow flexion. In the case of luxation, it is dislocated volar to the medial epicondyle. The nerve dislocation is often accompanied by a nerve swelling [2]. Further, space-occupying lesions such as ganglia, lipomas, arthritic changes, accessory muscles, or a dislocation of the medial triceps head (“snapping triceps syndrome”) can be reliably identified. In these Silmitasertib cost cases, the compression is often located proximal to the cubital tunnel, which may result in atypical electrophysiological findings. The diagnostic value of sonography is comparable with electrophysiological methods, in combination it improves the diagnostic yield. In addition,

it provides prognostic information: the extent of swelling in the sulcus correlates negatively with clinical improvement after surgery [8]. Since the less common compression syndromes affect mostly smaller nerves, the sonographic depiction of a direct nerve compression is more difficult. Therefore, the main role of sonography lies in the recognition of neighborhood processes as compression factors. Thus, sonography can detect space-occupying lesions such as ganglia or lipomas affecting the ulnar nerve in Guyon’s Loge, the median nerve at the proximal forearm, the interosseous posterior

nerve in the supinator tunnel, the axillary nerve in the quadrilateral space as well as the suprascapular nerve. In the so-called algetic interosseus-posterior-syndrome this website an ultrasound-guided infiltration can be performed for diagnostic purposes. In thoracic-outlet-sydrome, sonography can reveal a compression of the spinal nerve C7 or C8 by a cervical rib. In the lower extremities, peroneal nerve at the fibular head and tibial nerve in the tarsal tunnel can be affected by different soft tissue masses (enlarged bursae, ganglia, heterotopic ossification after trauma). Especially the peroneal nerve can be affected by intraneural ganglia emerging from tibiofibular joint via the articular branch [9]. In Morton’s metatarsalgia a “neuroma-like enlargment” of the second or third plantar interdigital nerve can be seen. Even in obese patients with meralgia paresthetica, a compression of the lateral femoral cutaneous nerve can be demonstrated and combined with an ultrasound-guided infiltration (personal experience).

Activity of putative matrix metalloproteinases 2 and 9 was detect

Activity of putative matrix metalloproteinases 2 and 9 was detected with gelatin zymography. Ten ontogenetic and 10 regenerated zebrafish scales were cultured for 20 h in 100 μl MEMα (Invitrogen). Zymography was done according to Bildt and co-workers [48]. Relative MMP activity was calculated from band intensity with Quantity One software (Bio-Rad, Hercules, USA) and related to 2 ng human recombinant

MDV3100 datasheet proMMP-2. GM6001 (ilomastat) from Millipore (Billerica, USA) was dissolved in DMSO at a concentration of 1 mg/ml. From two groups of six fish each, approximately 50 scales were removed from the left side of the fish. To specifically investigate MMP activity during scale plate remodelling, GM6001 exposure (100 nM) was started at day 2 in one group while the other group was exposed to the vehicle. Water was replaced every other day. On day 4 and day 7, three fish from each tank were sacrificed. Medium from overnight scale cultures was concentrated approximately fivefold by vacuum drying. Samples were loaded on a SDS-PAGE gel according to standard procedures. Proteins were transferred to an Immobilon-P PVDF membrane (Sigma-Aldrich) and used for Western blot with anti-MMP-9 (Anaspec) at a dilution of 1:1000. Biotinylated anti-rabbit IgG (Vector Laboratories, Burlingame, USA) was used as second antibody at a dilution of 1:1500. The Western

blot was developed with Vectastain ABC kit (Vector Laboratories) according to manufacturer’s instructions for staining with nickel-diaminobenzidine find more (Ni-DAB). Twenty scales (ontogenetic or 6 days regenerating) were taken from 6 fish and cultured overnight through in 200 μl MEMα. Collected culture medium was mixed with 400 μl 100% ethanol and allowed to precipitate overnight. Samples were centrifuged 15 min at 1710 g and supernatants were collected. Pellets were washed with 200 μl 70% ethanol and supernatants

were added to previously obtained supernatants. Samples were dried in a hot stove and then resuspended in 50 μl 2 M NaOH. Samples were autoclaved for 30 min and hydroxyproline was measured according to the method described by Reddy and Enwemeka [49]. In ontogenetic (non-plucked) scales of adult male zebrafish, mmp-9 expression was confined to cells on the episquamal side, along the radii and margins of the scale (see Figs. 1A, B, and D for whole-mounts and Figs. 1C and E for histological sections). Scleroblasts on the hyposquamal side showed no hybridisation; the mmp-9-positive cell population was confined mainly to the episquamal surface of the scale and included both mononucleated cells ( Figs. 1C and D) and multinucleated cells ( Figs. 1B and E). Fig. 1F shows a superimposed confocal image of plasma membranes stained with concanavalin A FITC conjugate. No separate plasma membranes were seen dividing the cytoplasmic mass of cells similar to the mmp-9 expressing cell in Fig. 1B.

Samples were run on an ABI 3100 Analyzer

and data were an

Samples were run on an ABI 3100 Analyzer

and data were analyzed Selleck Sirolimus using Genotyper software (Applied Biosystems, Foster City, CA). Tumors were categorized into 5 subtypes based on pathway-based classifications2, 20 and 21 using MMR status and mutations in BRAFV600E or KRAS, which were mutually exclusive ( Figure 1). We identified 3 pMMR subtypes: mutant BRAFV600E, mutant KRAS, or tumors lacking a mutation in either BRAFV600E or KRAS. Two subtypes were dMMR: sporadics with mutant BRAFV600E or hypermethylation of MLH1, or familial, which lack BRAF mutations or hypermethylation of MLH1, and have any KRAS status. To validate the prognostic utility of our subtype classifier, we examined an independent cohort of stage III colon carcinoma patients (N = 783) obtained from the Sage Bionetworks (Seattle, WA) consortium that consist of case series and a clinical trial cohort of well-annotated colon cancer patients with Veliparib research buy extended follow-up. Among these patients, 688 of 738 (93.2%) had received 5-FU–based adjuvant chemotherapy and of these 473 (64%) received 5-FU/leucovorin ± irinotecan in an adjuvant study (PETACC-3). Survival data was censored at 5 years with median follow-up

of 6.1 years; 269 DFS events were observed. Data for KRAS and BRAFV600E mutations and MMR status, determined by MMR protein expression or MSI, were used to classify patient tumors into the pheromone molecular subtypes as evaluated here. Deficient MMR tumors were divided based on BRAF status alone because data for MLH1 methylation were not available. All biomarker data were analyzed with investigators blinded to patient outcomes. For patients who were alive and disease-free, DFS was censored at the earlier date of last disease evaluation or 5 years post randomization. Analysis of the primary study end point of DFS, defined as time from date of randomization

to first documented disease recurrence or death (due to all causes), whichever occurred first, was reported previously.26 The 2 study arms were pooled given the lack of statistically significant differences in DFS rates,26 and the lack of a significant interaction (P > .38) between treatment and any of the biomarkers (ie, KRAS, BRAF, MMR) or the 5-level molecular subtype classification. Kruskal–Wallis (or Wilcoxon rank-sum) and χ2 (or Fisher’s exact) tests were used to compare continuous and categorical variables, respectively, among the 5 subtypes. Median follow-up for surviving patients was 4.9 years (range, 0.0–8.4 years). Kaplan-Meier methods were used to describe the distributions of DFS. 30 Univariate Cox proportional hazard models 31 were used to explore the associations of patient characteristics and biomarkers with DFS.

Samples kept at 30 °C were only used to evaluate oxidative stabil

Samples kept at 30 °C were only used to evaluate oxidative stability. Samples were taken every month and analyzed for all parameters. Chemical composition of all six chocolate samples http://www.selleckchem.com/products/PLX-4032.html was determined according to the AOAC methods (AOAC, 2005). Carbohydrates were obtained by difference. Mechanical properties of chocolates (hardness) were measured according to the method proposed by Afoakwa, Paterson,

Fowler, and Vieira (2008) using TA-XT2 Texture Analyzer (Stable Micro Systems, Surrey, UK). Maximum penetration and withdrawal forces through a sample were determined (1.0 mm/s, 5 mm of penetration at 20 °C). The color of dark chocolate was measured using a ColourQuest-XE colorimeter (Hunter Assoc. Laboratory, Reston, USA), using the CIE standard illuminant D65 as reference. Ten grams per sample were compressed into an optical cell (vision area 0.37 pol.). Color was expressed as lightness (L*), redness (a*) and yellowness (b*), using CIELab

parameters. A hedonic sensory evaluation was carried out by an untrained panel consisting of thirty individuals composed by the students and employees from the Faculty staff, who liked of bitter chocolate. Approximately 10 g of dark chocolate was placed in a small plate coded with 3-digit random numbers. Each panelist received a set of 3 samples (CONT, PHYT and PHAN) in a different order (3!), and they were instructed to rinse their mouth with water between samples evaluation. Acceptability analysis was performed using a 9 point hedonic scale, considering 9 as “extremely like” and 1 as

“extremely dislike”. The selleck screening library Parvulin extraction of chocolate lipids was performed according to AOAC official method 920.75 (AOAC, 2002). About 5 g of the chocolate bars was mixed with 10 mL diethyl ether for 1 min. The tubes were centrifuged and the upper phase separated. The extraction was repeated twice and the combined extract was filtered using sodium sulfate. Ether extracts were evaporated and resuspended with 1 mL of hexane. Hydroperoxide content of the extracted fat was determined according to Shantha and Decker (1994). PV was determined in 50 μL of lipid extract at 510 nm, by using a UV–VIS mini 1240 spectrophotometer (Shimadzu, Kyoto, Japan), and it was calculated from the absorbance. The hydroperoxide content was determined using a standard curve prepared with known concentrations of cumene hydroperoxide. Concentrations were expressed as mmol/kg of fat. The chocolates fatty acid profile was determined according to AOCS Ce 1b-89 (AOCS, 2001). The chromatographic analysis was carried out using a gas chromatograph GC (Agilent 7890 A GC System, Agilent Technologies Inc., Santa Clara,USA). A fused silica capillary column (J&W DB-23 Agilent 122-236; 60m × 0.25 mm i.d., 0.15 μm film thickness) was used for injection.

Only COCs with homogenous cytoplasm and at least three layers of

Only COCs with homogenous cytoplasm and at least three layers of cumulus cells were used in the experiments. In a glass tube, a stock solution (SS) with 1 g of methyl-β-cyclodextrin was dissolved in 2 mL of methanol and stored at −20 °C [10]. To load cholesterol

from FCS, the SS was diluted with different concentrations (1, 2 or 3 mg) of MβCD in 1 mL of HEPES-buffered TCM-199 (GIBCO® BRL) supplemented with 20% FCS. The solution was incubated overnight at 38.5 °C. Oocyte vitrification was performed as previously described [12] IGF-1R inhibitor with slight modifications. The holding medium (HM), which was used to handle oocytes during vitrification and warming, was composed of HEPES-buffered TCM-199 (GIBCO® BRL) supplemented

with 20% FCS. For vitrification, groups were first washed three times in an equilibrium solution composed of 7.5% ethylene glycol and 7.5% dimethylsulfoxide (Me2SO) dissolved in HM for a total of 9 min. Oocytes were transferred Etoposide mouse to a vitrification solution of 15% ethylene glycol, 15% Me2SO and 0.5 M of sucrose in HM where they were incubated for 45–60 s. Next, the oocytes were placed into the cryotop device in sets of 3–5 under a stereomicroscope. Before vitrification, most of the solution that was transferred with the oocytes was removed from the device, and only a thin layer (<0.1 μl) remained to cover the oocytes. Subsequently, the cryotop device was immediately submerged into liquid nitrogen. Warming was performed immediately after vitrification by immersing the cryotop end into a drop of HM supplemented with 1 M of sucrose for 1 min pre-warmed at 37 °C. The oocytes were transferred to HM medium supplemented with 0.5 M of sucrose for 3 min, respectively, and finally to the original holding medium.

Afterwards, the oocytes were placed in the culture dishes to mature or were fixed for maturational stage evaluation. After Amrubicin warming, COCs were washed and transferred (groups of 25–30) to a 200 μL drop of maturation medium under silicone oil and incubated for 22 h at 39 °C in 5% CO2 in air. The maturation medium was TCM-199 supplemented with 10% FCS (v/v), 10 mg/mL of FSH and antibiotics (100 IU/mL of penicillin and 50 mg/mL of streptomycin). CCOs were distributed into 4 groups, each group represented one maturation period. The first one was fixed immediately after selection, before IVM; the second group was fixed with 8 h of IVM; the third was fixed 22 h of IVM and the fourth group completed IVM period and was fixed with 24 h of IVM. For meiotic progression evaluation, oocytes were denuded and fixed for at least 48 h with acetic alcohol (1:3). On the day of the evaluation, these oocytes were placed on a slide, covered with a coverslip and were stained with 1% lacmoid in 45% glacial acetic acid. The maturational stage of each oocyte was determined using phase contrast microscopy.


“The prototype dioxin congener 2,3,7,8-tetrachlorodibenzo-


“The prototype dioxin congener 2,3,7,8-tetrachlorodibenzo-p-dioxin

(TCDD) is a highly toxic and persistent organic pollutant, which is ubiquitously found in the environment. There is extensive evidence in vivo and in vitro that TCDD exerts anti-estrogenic effects via activation of the arylhydrocarbon receptor (AhR) by interfering with the regulation of estrogen homeostasis and the estrogen receptor α (ERα) signaling pathway (reviewed in [1]). A number of mechanisms were proposed to describe dioxin-mediated AhR/ERα cross-talk ( [2] and [3]; Safe et al., 2000). It was hypothesized that TCDD may interfere with the regulation of estrogen homeostasis resulting in reduced concentrations of circulating estrogens. This is learn more thought to result from enhanced oxidative metabolism of 17β-estradiol (E2) via AhR-mediated induction of cytochromes P450 (CYPs), particularly CYP1A1 and CYP1B1 [4]. The latter also serve as general surrogate markers for AhR activation [5]. Furthermore, TCDD may also prevent binding of the E2/ER-complex to the estrogen response element (ERE) and instead recruit Avasimibe nmr the hormone receptor to AhR target genes via an indirect protein-protein interaction [6] and [7]. It was shown that E2-dependent expression of genes and proteins such as

pS2, cathepsin D and vitellogenin. were inhibited by the action of TCDD [8]. Furthermore, TCDD was reported to inhibit E2-induced cell proliferation and

DNA synthesis by specifically blocking the E2-induced transition from G1 to S phase [9]. TCDD also induced the degradation of ERα through activation of the proteasome as observed in breast cancer cell lines [10] and it mediated the down-regulation of ER levels via a repressor site in the promoter region of ER-regulated genes [3]. Most of these studies were performed using breast cancer cell lines or other hormone-related cells and focused on AhR agonists which directly affected ERα-dependent pathways [11], [12] and [13]. In contrast, TCDD did not show direct activation of ERα in a competitive binding assay [14]. TCDD has been classified as a human carcinogen by the International Agency for Research on Cancer [15], its carcinogenic effect in rodent liver being most probably related to its mode of action as a liver tumour Amylase promoter [5]. AhR signaling-dependent suppression of apoptosis of preneoplastic hepatocytes seems to play a central role in this effect [16]. Interestingly, TCDD was found to be a more potent liver carcinogen in female rats compared to male rats and it reduced age-related spontaneous hormone-dependent tumours, suggesting a role of estrogens [17] and [18]. Exposure to E2 is primarily associated with increased risk of breast cancer [19]. However, E2 was also related to liver carcinogenesis and it has been postulated to promote ER-mediated growth stimulation via co-mitogenic effects [20].

The most common number of specimens submitted in this dataset was

The most common number of specimens submitted in this dataset was 2 (Fig. 1). Two specimens usually can be collected by using one pass of the biopsy forceps. A second pass of the forceps, done for the purpose of collecting additional specimens, increases the length of the procedure. Although the amount of time for an additional pass of the biopsy forceps for additional biopsies is low (approximately 1 minute), the incremental yield of this additional time taken

was heretofore MK-2206 manufacturer unknown. Given the high incremental yield in the present analysis (resulting in a doubling of the proportion of patients with a pathological diagnosis of CD), the proposed standard of submitting ≥4 specimens appears to be justified. We observed a marked variability between individual endoscopists with regard to the proportion of examinations in which the recommended number of specimens was submitted. Although the mean adherence rate among providers was 38.3%, the most common percentage adherence per individual was between 0% and 10%. The wide variability in adherence to this recommendation is reminiscent of the variability of a familiar quality indicator in gastroenterology, PD0332991 research buy the adenoma detection

rate in screening colonoscopy.22 The discovery of that variability and associated predictive factors such as colonoscope withdrawal time23 has led to a focus on high-quality colonoscopy as a priority for the profession of gastroenterology.24 The findings in the present study, of low adherence to a recommendation in the face of a high diagnostic yield of submitting ≥4 specimens, should spur efforts to increase adherence to this standard. This study has several limitations. This was a retrospective analysis of a pathology tissue database, which

has nevertheless yielded high-quality analyses of GI epidemiology and quality measures.25 and 26 In this database, we did not have access in all patients to key variables that influence the likelihood of CD, such as data regarding family history of CD or serology results. Those with positive CD serology results (ie, noted in the clinical indication field) were classified Edoxaban in the “suspected CD” indication category; this variable was included in the multivariate analysis. Information regarding the type of sedation used during the procedure and degree of sedation, which may have impacted the ability to obtain ≥4 specimens, was not available. The diagnosis of CD in this study was based strictly on histopathologic findings, and reliance on histology alone has been criticized for its lack of specificity.27 For this reason, we considered only the most severe histopathologic changes (Marsh III lesions) as CD, excluding the increasingly common report of increased intraepithelial lymphocytosis, so as to maximize the specificity of the outcome in this analysis. Certain providers may have a particular interest or expertise in CD and thus are more likely to submit ≥4 specimens.

T cells are central players in the process of transplant rejectio

T cells are central players in the process of transplant rejection and are involved both in the acute and chronic rejection phases, presenting an important target for immunosuppressive drugs. They drive graft rejection by direct and indirect

mechanisms including apoptosis induction by cytotoxic T cells, cytokine release by T helper cells and by promoting T-dependent alloantibody responses [1]. Activation of allograft-specific T cells is induced by antigen presenting cells such as dendritic cells from both the donor and the host. Binding of MHC–allopeptide complexes to the T cell receptor together with concurrent costimulation triggers http://www.selleckchem.com/products/sch772984.html intracellular signal cascades leading to the activation and expansion of CX-5461 ic50 alloreactive T cells [5]. The members of the Vav family of guanine nucleotide exchange factors (GEFs) are central signaling molecules downstream of antigen

receptors, and their deficiency severely affects antigen receptor signaling, lymphocyte development, activation and proliferation [6]. While Vav2 and Vav3 show a broad expression, Vav1 is primarily expressed in hematopoietic cells. Upon T cell receptor (TCR) engagement, Vav1 is phosphorylated and recruited to a TCR-proximal signaling complex including LAT, SLP76, GADS and phospholipase C γ1 (PLCγ1). Vav1 has been shown to integrate various different signal transduction pathways downstream of the TCR and costimulatory receptors leading to gene expression, cytoskeletal reorganization and proliferation [7]. Mice deficient for Vav1 show defects in thymic very T cell development and activation of peripheral T cells [8]. T cells lacking

Vav1 show reduced Ca2+flux, defective activation of extracellular signal-regulated kinase (ERK), Protein kinase C (PKC), the serine–threonine kinase Akt and T cell-APC conjugate formation [9], [10], [11], [12] and [13]. Vav proteins contain a Dbl homology (DH) domain, which together with the adjacent plekstrin homology (PH) and C1 domains confers GEF activity toward the Rho-family GTPases Rac, Cdc42 and RhoA [14] and [15]. In addition, they contain SH2 and SH3 domains which may mediate the GEF-independent functions of Vav. Phosphorylation of regulatory tyrosines in the acidic domain relieves the autoinhibitory interactions resulting in formation of the open, active conformation and activation of its GEF activity [16] and [17]. The relative contribution of the GEF-dependent and GEF-independent function of Vav1 for T cell signal transduction and activation still remains unclear. Conditional deletion of Rac1 and Rac2 resulted in a developmental block at the pre-TCR stage, resembling the phenotype of Vav1-deficient mice [18]. In addition, impaired T cell development in Vav1-deficient mice can be rescued by overexpression of constitutively active Rac1, indicating that Vav1 transduces pre-TCR signals via Rac1 [19].

1m The second wave is influxed from the x  -axis for x∈[11,150]x

1m. The second wave is influxed from the x  -axis for x∈[11,150]x∈[11,150] and has period 2.2s, amplitude 0.1m and makes an angle

AZD6738 manufacturer of 30°30° with the positive x-axis. Simulation of the nonlinear bidirectional biharmonic waves is done with influxing for individual flap motion using the source term given by (21) in the nonlinear AB2-spectral code. The simulated elevation is shown in the density plot of Fig. 9 at time t=300s; the time signals at one position are compared with measurements for each individual wave and for the two waves together. The interaction shows the characteristic pattern of oblique bichromatic waves with small nonlinear effects. 1D simulations with the finite element VBM code are performed to illustrate six different influxing methods. Elevation FG-4592 concentration and velocity influxing is used to generate symmetric or skew-symmetric bi-directional waves or to produce only forward propagation waves. Area influxing is used with taking for the spatial function in the sources (11) the function γ(x)γ(x) related to the group velocity in Fourier space (2). The six simulations are done for 60s on 1m water depth. The computational domain is from x=−50m until x=50m with the wave generation at the origin. The signal to be influxed is chosen to be a bipolar given by η0(t)=0.2(t−30)exp(−(t−30)2)η0(t)=0.2(t−30)exp(−(t−30)2)The

corresponding initial signal for the velocity influxing is found from u0(t)=^iK1(ω)ϕ^0 with ϕ^0=(−ig)η^0(ω)/ω. second Fig. 10 shows plots of the simulation results for the wave profile at time 40s; both elevation and velocity generation give the same result as expected. In a rather straightforward way source functions have been derived that are added to first and second order time equations of Boussinesq type to

generate desired wave fields. It was shown that the source functions are not unique, but that the temporal–spatial Fourier transform is unique when the dispersion relation is satisfied. This ambiguity of the source function has been exploited to reduce or enlarge the extent of the generation area. Influxing from a point or line requires the modified signal to be higher, due to the multiplication in temporal Fourier space with the group velocity of the desired influx signal; for generation areas of larger extent, the modified signal is lower, but the waves are only accurate outside the generation area. Various test cases shown above illustrated the quality of wave generation by comparing with experimental data. The generation methods presented here were used in various other cases, such as simulations of irregular waves entering a harbour and simulation of bi-modal sea states consisting of swell and wind waves for research on predicting elevation at the position of a radar that scans the surrounding area with a nautical x-band radar. A report about nonlinear simulations for MARIN experiments of short crested waves is in preparation.